Abstract:Background Computational fluid dynamics (CFD) simulations, in-vitro setups, and experimental ex-vivo approaches have been applied to numerous alveolar geometries over the past years. They aimed to study and examine airflow patterns, particle transport, particle propagation depth, particle residence times, and particle-alveolar wall deposition fractions. These studies are imperative to both pharmaceutical and toxicological studies, especially nowadays with the escalation of the menacing COVID-19 virus. However, most of these studies ignored the surfactant layer that covers the alveoli and the effect of the air-surfactant surface tension on flow dynamics and air-alveolar surface mechanics. Methods The present study employs a realistic human breathing profile of 4.75s for one complete breathing cycle to emphasize the importance of the surfactant layer by numerically comparing airflow phenomena between a surfactant-enriched and surfactant-deficient model. The acinar model exhibits physiologically accurate alveolar and duct dimensions extending from lung generations 18 to 23. Airflow patterns in the surfactant-enriched model support previous findings that the recirculation of the flow is affected by its propagation depth. Proximal lung generations experience dominant recirculating flow while farther generations in the distal alveolar region exhibit dominant radial flows. In the surfactant-enriched model, surface tension values alternate during inhalation and exhalation, with values increasing to 25 mN/m at the inhalation and decreasing to 1 mN/m at the end of the exhalation. In the surfactant-deficient model, only water coats the alveolar walls with a high surface tension value of 70 mN/m. Results Results showed that surfactant deficiency in the alveoli adversely alters airflow behavior and generates unsteady chaotic breathing through the production of vorticities, accompanied by higher vorticity magnitudes (100% increases at the end of exhalation) and higher velocity magnitudes (8.69% increases during inhalation and 11.9% increases during exhalation). In addition, high air-water surface tension in the surfactant-deficient case was found to induce higher shear stress values (by around a factor of 10) on the alveolar walls than that of the surfactant-enriched case. Conclusion Overall, it was concluded that the presence of the surfactant improves respiratory mechanics and allows for smooth breathing and normal respiration.

Effect of Amphotericin B on the Thermodynamic Properties and Surface Morphology of the Pulmonary Surfactant Model Monolayer during Respiration

Short-Course Rather Than Low-Dose Amphotericin B May Exert Potential Influence on Mortality in Cryptococcal Meningitis Patients Treated with Amphotericin B Plus Flucytosine Alone or in Combination with Fluconazole

[Clinical Study of Amphotericin B in the Treatment of Invasive Fungal Infection in 111 Hematological Disorder Patients with Neutrocytopenia].

Effects of Different Concentrations of AmB on the Unsaturated Phospholipid–Cholesterol Membrane Using the Langmuir Monolayer and Liposome Models

Computational Investigations of the Interaction Between the Cell Membrane and Nanoparticles Coated with a Pulmonary Surfactant.

Bioactivity, Safety, and Efficacy of Amphotericin B Nanomicellar Aerosols Using Sodium Deoxycholate Sulfate as the Lipid Carrier

SARS-CoV-2 infection enhancement by Amphotericin B: Implications for disease management

Could the Lung Be a Gateway for Amphotericin B to Attack the Army of Fungi?

Study Interactions Between Inhaled Nanoparticles and Pulmonary Surfactant Using Molecular Dynamics Simulations

Experiments and modelling of pulmonary surfactant disruption by aerosolised compounds

Application and evaluation of topical amphotericin B for the treatment of respiratory fungal infections

Constrained drop surfactometry for studying adsorbed pulmonary surfactant at physiologically relevant high concentrations

Poly(amidoamine) Dendrimer As a Respiratory Nanocarrier: Insights from Experiments and Molecular Dynamics Simulations

Nanoparticle Translocation Across the Lung Surfactant Film Regulated by Grafting Polymers.

Insights Gained Into the Treatment of COVID19 by Pulmonary Surfactant and Its Components

Amphotericin B and monoacyl-phosphatidylcholine form a stable amorphous complex

Effect of the Surface Charge Density of Nanoparticles on Their Translocation Across Pulmonary Surfactant Monolayer: a Molecular Dynamics Simulation

Formulation Strategies to Overcome Amphotericin B Induced Toxicity

Surface tension effects on flow dynamics and alveolar mechanics in the acinar region of human lung

A Theoretical Analysis of Interaction Energies and Intermolecular Interactions between Amphotericin B and Potential Bioconjugates Used in the Modification of Nanocarriers for Drug Delivery